PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsinfections
MeSH D007239 - infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007239: 
Infections
2 Companies
2 Drugs
$
Success rate
D000069578:Waterborne diseases
0 Companies
0 Drugs
Success rate
D000079263:Vaccine-preventable diseases
0 Companies
0 Drugs
Success rate
D000079426:Vector borne diseases
0 Companies
0 Drugs
Success rate
D000085343:Latent infection
0 Companies
0 Drugs
Success rate
D000088562:Persistent infection
0 Companies
0 Drugs
Success rate
D000785:Infected aneurysm
0 Companies
0 Drugs
Success rate
D001170:Infectious arthritis
37 Companies
7 Drugs
$
Success rate
D001423:Bacterial infections and mycoses
2 Companies
3 Drugs
$
Success rate
D001850:Infectious bone diseases
85 Companies
26 Drugs
$
Success rate
D002494:Central nervous system infections
60 Companies
7 Drugs
$
Success rate
D003141:Communicable diseases
15 Companies
2 Drugs
$
Success rate
D003428:Cross infection
2 Companies
2 Drugs
$
Success rate
D005490:Focal infection
0 Companies
0 Drugs
Success rate
D005891:Gingivitis
0 Companies
0 Drugs
Success rate
D006520:Animal hepatitis
0 Companies
0 Drugs
Success rate
D007757:Laboratory infection
0 Companies
0 Drugs
Success rate
D009894:Opportunistic infections
0 Companies
0 Drugs
Success rate
D010272:Parasitic diseases
0 Companies
0 Drugs
Success rate
D011251:Infectious pregnancy complications
32 Companies
5 Drugs
$
Success rate
D012141:Respiratory tract infections
98 Companies
34 Drugs
$
Success rate
D012749:Sexually transmitted diseases
0 Companies
0 Drugs
Success rate
D012874:Infectious skin diseases
99 Companies
28 Drugs
$
Success rate
D013492:Suppuration
0 Companies
0 Drugs
Success rate
D014115:Toxemia
0 Companies
0 Drugs
Success rate
D014552:Urinary tract infections
184 Companies
97 Drugs
$
Success rate
D014777:Virus diseases
23 Companies
10 Drugs
$
Success rate
D014946:Wound infection
31 Companies
7 Drugs
$
Success rate
D015047:Zoonoses
0 Companies
0 Drugs
Success rate
D015817:Eye infections
0 Companies
0 Drugs
Success rate
D016459:Prosthesis-related infections
0 Companies
0 Drugs
Success rate
D017714:Community-acquired infections
15 Companies
8 Drugs
$
Success rate
D018461:Soft tissue infections
137 Companies
62 Drugs
$
Success rate
D018805:Sepsis
26 Companies
9 Drugs
$
Success rate
D031261:Poult enteritis mortality syndrome
0 Companies
0 Drugs
Success rate
D034161:Pelvic infection
26 Companies
8 Drugs
$
Success rate
D053821:Cardiovascular infections
0 Companies
0 Drugs
Success rate
D055499:Catheter-related infections
0 Companies
0 Drugs
Success rate
D058345:Asymptomatic infections
0 Companies
0 Drugs
Success rate
D059413:Intraabdominal infections
88 Companies
24 Drugs
$
Success rate
D060085:Coinfection
0 Companies
0 Drugs
Success rate
D060737:Reproductive tract infections
0 Companies
0 Drugs
Success rate
D000093742:Breakthrough infections
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
PAIONEravacycline Xerava  2018-09-20   
Clinical Trials
Historical Success Rate
Phase 1
71%
69/97
Phase 2
60%
62/104
Phase 3
50%
72/144
Approved: 1Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
X4 Pharmaceuticals
Mavorixafor
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use